Gene Ontology annotation through association of InterPro records with GO terms
Manual transfer of experimentally-verified manual GO annotation data to orthologs by curator judgment of sequence similarity
Annotation inferences using phylogenetic trees
Gene Ontology annotation based on UniProtKB/Swiss-Prot keyword mapping
Combined Automated Annotation using Multiple IEA Methods
Cloning and characterization of a lymphoid-specific, inducible human protein tyrosine phosphatase, Lyp.
-
PTPN22 encodes a 105-kD intracellular phosphatase with a single PTP catalytic domain and four proline-rich SH3 binding sites
"We have isolated a previously undescribed human phosphatase, Lyp, that encodes an intracellular 105-kD protein containing a single tyrosine phosphatase catalytic domain. The noncatalytic domain contains four proline-rich potential SH3 domain binding sites"
-
Constitutive association with c-Cbl in thymocytes and T cells
"Lyp1 was found to be constitutively associated with the proto-oncogene c-Cbl in thymocytes and T cells."
-
Predominantly expressed in lymphoid tissues and cells
"The lyp phosphatases are predominantly expressed in lymphoid tissues and cells, with Lyp1 being highly expressed in thymocytes and both mature B and T cells."
Subcellular localization of intracellular protein tyrosine phosphatases in T cells.
-
PTPN22 (PEP) found in cytosol and enriched at plasma membrane in T cells
"Most were found in the cytosol and many were enriched at the plasma membrane."
-
Nuclear localization also detected
"15 of the currently known 24 intracellular PTPases are expressed in T cells"
-
15 of 24 known intracellular PTPs expressed in T cells
"We report that 15 of the currently known 24 intracellular PTPases are expressed in T cells"
Identification of substrates of human protein-tyrosine phosphatase PTPN22.
-
Identified Lck, ZAP-70, TCR-zeta, Vav, VCP, CD3-epsilon as PTPN22 substrates by substrate trapping
"Several potential substrates were identified in lysates from pervanadate-stimulated Jurkat cells using PTPN22-D195A/C227S, an optimized substrate trap mutant of PTPN22."
-
Dephosphorylates Lck at Tyr-394 and ZAP-70 at Tyr-493 (activating tyrosines)
"Native PTPN22 dephosphorylated Lck and Zap70 at their activating tyrosine residues Tyr-394 and Tyr-493, respectively"
-
Does not dephosphorylate inhibitory tyrosines (Lck Tyr-505, ZAP-70 Tyr-319)
"but not at the regulatory tyrosines Tyr-505 (Lck) or Tyr-319 (Zap70)"
Structure, inhibitor, and regulatory mechanism of Lyp, a lymphoid-specific tyrosine phosphatase implicated in autoimmune diseases.
-
Crystal structure of PTPN22 catalytic domain at 2.8 Angstroms
"we report the identification of a bidentate salicylic acid-based Lyp inhibitor I-C11 with excellent cellular efficacy"
-
Ser-35 phosphorylation by PKC regulates PTPN22 substrate recognition
"We show that Lyp is phosphorylated exclusively at Ser-35 by PKC both in vitro and in vivo."
-
Ser-35 phosphorylation impairs ability to inactivate Src family kinases
"Ser-35 phosphorylation impairs Lyp's ability to inactivate the Src family kinases and down-regulate T cell receptor signaling."
Reduced CD4+T cell activation in children with type 1 diabetes carrying the PTPN22/Lyp 620Trp variant.
-
R620W variant associated with reduced CD4+ T cell activation
"The LYP 620Trp variant is associated with reduced activation, proliferation and IL-2 production in CD4(+)T cells among T1D patients."
-
Decreased proliferation, IL-2 production, and calcium flux in T1D patients
"a profoundly decreased intracellular calcium flux in CD4(+)T cells after PHA stimulus was detected among 620Trp carriers"
Cutting edge: the PTPN22 allelic variant associated with autoimmunity impairs B cell signaling.
-
R620W variant impairs B cell signal transduction
"B cell signal transduction is impaired in individuals who express the variant."
-
Reduced proliferation and phosphorylation of key signaling proteins
"This defect in signaling is characterized by a deficit in proliferation, a decrease in phosphorylation of key signaling proteins"
-
Reversed by Lyp inhibition
"and is reversed by inhibition of Lyp"
Research progress of several protein tyrosine phosphatases in diabetes
-
Review article describing PTPN22/LYP as cytoplasmic phosphatase in T cells
"The tyrosine phosphatase LYP, which down-regulates LCK activity in T cell response"
-
R620W variant may be gain-of-function for phosphatase activity
"LYP R620W may be a gain of function mutation which suppresses TCR signaling."
PTPN22 gene regulates natural killer cell proliferation during in vitro expansion.
-
rs2476601 CT genotype associated with reduced NK cell expansion in vitro
"The CT genotype of the rs2476601 SNP was significantly (P = 0.0013) associated with reduced NK cell CD3(-) CD56(+) fraction in culture."
-
Suggests PTPN22 has immune regulatory role in NK cells
"the PTPN22 gene might have an important immune regulatory role in NK cell function which needs further investigation"
The autoimmunity-associated gene PTPN22 potentiates toll-like receptor-driven, type 1 interferon-dependent immunity.
-
PTPN22 selectively regulates type I IFN production after TLR engagement
"Ptpn22 selectively regulated type 1 IFN production after TLR engagement in myeloid cells."
-
PTPN22 directly associates with TRAF3 and promotes K63-linked ubiquitination
"PTPN22 directly associated with TNF receptor-associated factor 3 (TRAF3) and promotes TRAF3 lysine 63-linked ubiquitination."
-
R620W variant fails to promote TRAF3 ubiquitination and type I IFN
"The disease-associated PTPN22W variant failed to promote TRAF3 ubiquitination, type 1 IFN upregulation"
-
Establishes innate immune mechanism of action for autoimmune risk gene
"Ptpn22 promoted host antiviral responses and was critical for TLR agonist-induced, type 1 IFN-dependent suppression of inflammation in colitis and arthritis"
Protein tyrosine phosphatase non-receptor type 22 modulates NOD2-induced cytokine release and autophagy.
-
MDP treatment induces PTPN22 expression and enzymatic activity
"MDP-treatment induced PTPN22 expression and activity in human and mouse cells."
-
PTPN22 knockdown enhances p38, JNK MAPK activation but reduces ERK
"Loss of PTPN22 enhanced basal and MDP-induced phosphorylation of p38 and MDP-induced JNK phosphorylation."
-
PTPN22 knockdown enhances IL-6, IL-8, TNF secretion
"PTPN22 deficiency finally resulted in enhanced secretion of the pro-inflammatory cytokines IL-6, IL-8 and TNF in human THP-1 monocytes"
-
PTPN22 knockdown enhances autophagosome formation
"Additionally, loss of PTPN22 resulted in increased, MDP-mediated autophagy in human and mouse cells."
-
PTPN22 controls NOD2 signaling in innate immune cells
"PTPN22 controls NOD2 signaling, and loss of PTPN22 renders monocytes more reactive towards bacterial products"
NLRP3 tyrosine phosphorylation is controlled by protein tyrosine phosphatase PTPN22.
-
PTPN22 dephosphorylates NLRP3 at Tyr-861
"dephosphorylates NLRP3 upon inflammasome induction, allowing efficient NLRP3 activation and subsequent IL-1β release"
-
Dephosphorylation allows efficient NLRP3 inflammasome activation and IL-1beta release
"protein tyrosine phosphatase non-receptor 22 (PTPN22), variants in which are associated with chronic inflammatory disorders, dephosphorylates NLRP3 upon inflammasome induction"
-
PTPN22 deficiency increases NLRP3 phosphorylation and reduces IL-1beta
"PTPN22 deficiency resulted in pronounced colitis, increased NLRP3 phosphorylation, but reduced levels of mature IL-1β"
Inactivation of LCK by PTPN22
PTPN22 dissociates from CSK
PTPN22 dephosphorylates ZAP70
Deep research review of PTPN22 function (Falcon/Edison)
-
Comprehensive review of PTPN22 structure, function, substrates, and disease associations
-
Summarizes 2023-2024 literature on PTPN22 mechanisms